Seeyond’s Bristol-Myers Squibb BMY Stock Holding History

Seeyond’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$6.38M	Buy	88,662 +41,016	+86%	+$3.09M	0.62%	20
2022 Q3	$3.39M	Sell	47,646 -2,264	-5%	-$164K	0.41%	53
2022 Q2	$3.84M	Sell	49,910 -49,977	-50%	-$3.81M	0.44%	38
2022 Q1	$7.29M	Sell	99,887 -6,029	-6%	-$405K	0.73%	14
2021 Q4	$6.6M	Sell	105,916 -7,302	-6%	-$428K	0.61%	18
2021 Q3	$6.7M	Sell	113,218 -30,604	-21%	-$2.02M	0.65%	19
2021 Q2	$9.61M	Sell	143,822 -18,331	-11%	-$1.2M	0.9%	10
2021 Q1	$10.2M	Sell	162,153 -5,795	-3%	-$361K	1.03%	7
2020 Q4	$10.4M	Buy	167,948 +37,877	+29%	+$2.33M	1.08%	7
2020 Q3	$7.84M	Sell	130,071 -15,566	-11%	-$937K	0.85%	18
2020 Q2	$8.56M	Buy	145,637 +11,910	+9%	+$712K	0.97%	14
2020 Q1	$75K	Buy	133,727 +7,133	+6%	+$436K	0.01%	589
2019 Q4	$8.13M	Sell	126,594 -18	-0%	-$1.03K	0.85%	10
2019 Q3	$6.42M	Sell	126,612 -28,824	-19%	-$1.35M	0.67%	19
2019 Q2	$7.05M	Buy	155,436 +5,454	+4%	+$254K	0.73%	15
2019 Q1	$7.16M	Buy	149,982 +102,147	+214%	+$5.09M	0.68%	15
2018 Q4	$2.49M	Buy	+47,835	New	+$2.57M	0.34%	66

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Seeyond's BMY Position: Q4 2022 in Review

Seeyond increased its Bristol-Myers Squibb (BMY) stake by 86% in Q4 2022, buying an estimated $3.09M and bringing the position to 88,662 shares worth $6.38M. The position accounts for 0.62% of the portfolio, ranked #20.

Seeyond first reported a position in BMY in Q4 2018 and has held it in 17 quarters since. The position peaked at $10.4M in Q4 2020. 2,600 funds tracked by Wall St. Rank hold BMY as of Q4 2022.

Seeyond held 88,662 shares of Bristol-Myers Squibb worth $6.38M as of Q4 2022.
Seeyond bought 41,016 Bristol-Myers Squibb shares in Q4 2022, an estimated $3.09M.
Bristol-Myers Squibb made up 0.62% of Seeyond's portfolio in Q4 2022, its #20 holding.
Seeyond first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 17 quarters since.
Seeyond's Bristol-Myers Squibb position peaked at $10.4M in Q4 2020.
2,600 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.

Based on Seeyond's 13F filing for Q4 2022, filed 13 Feb 2023.